Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for technology industry professionals · Tuesday, March 19, 2024 · 696,991,833 Articles · 3+ Million Readers

Reliq Losses Alert: Bernstein Liebhard LLP Announces Investigation of Reliq Health Technologies Inc. - RQHTF

NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Reliq Health Technologies Inc. (“Reliq” or the “Company”) (OTCQB: RQHTF) resulting from allegations that Reliq and/or its executives may have issued materially misleading business information to the investing public.

If you purchased Reliq securities, and/or would like to discuss your legal rights and options, please visit Reliq Shareholder Investigation or contact Daniel Sadeh toll free at (877) 779-1414 or dsadeh@bernlieb.com.

On October 16, 2018, Reliq disclosed “that it has decided to restate certain financial information reported for the quarter ended March 31, 2018.” The Company stated that “[t]he decision to restate followed a review conducted by the Company’s auditor and Audit Committee, wherein it was determined that the timing and certainty of receiving the revenue invoiced to clients is substantially unclear, due to clients’ issues with securing reimbursement from the payor.” The Company further revealed that “[t]he material changes to be included in the restatement will affect the Company’s revenue and are projected to increase the Company’s loss and comprehensive loss for Fiscal Year 2018. In addition, the Company’s Board of Directors have taken the position that no revenue will be reported for Q4 of fiscal 2018 until revenue collection issues are resolved.”

On this news, Reliq stock fell $0.32 per share, or over 55%, from its previous closing price to close at $0.26 per share on October 16, 2018, damaging investors.

If you purchased Reliq securities, and/or would like to discuss your legal rights and options, please visit https://www.bernlieb.com/cases/reliq-health-technologies-inc-rqhtf-lawsuit-class-action-fraud-stock-89/ or contact Daniel Sadeh toll free at (877) 779-1414 or dsadeh@bernlieb.com.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2018 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Daniel Sadeh
Bernstein Liebhard LLP
http://www.bernlieb.com 
(877) 779-1414
dsadeh@bernlieb.com  

BL-new-logo.jpg

Powered by EIN News
Distribution channels: Technology


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release